Simplify Logo

Full-Time

VP of Finance

Confirmed live in the last 24 hours

Valo Health

Valo Health

51-200 employees

Drug discovery using machine learning technology

AI & Machine Learning
Biotechnology

Senior, Expert

Lexington, MA, USA

Category
Corporate Finance
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
Data Analysis
Requirements
  • 10+ years of financial and accounting experience in the life sciences / biotechnology industry. Experience leading finance for a company through a successful IPO strongly preferred.
  • BS/BA in accounting or finance; MBA and/or CPA preferred.
  • Strong business acumen; proven ability to effectively scrutinize and challenge assumptions and interpret the strategy and priorities of the organization in financial terms.
  • Excellent project management / leadership skills with demonstrated track record and ability to engage teams to work together towards common deadlines.
  • Strong presentation skills to deliver succinctly and effectively deliver recommendations to senior leaders; frames complex concepts.
Responsibilities
  • Partner with the leadership team to understand critical scientific and operational decisions and the related financial impact
  • Partner with the leadership team to create a long range plan, milestones and financial projections
  • Create, maintain and track annual budgets and monthly forecasts
  • Manage cash flow vs financing needs and strategic scientific milestones
  • Board of Directors financial presentations and corporate governance
  • Oversee month end closes and reporting
  • Build finance team to support accounts payable and payroll
  • Management of lease, contracts, consulting agreements and other financial commitments
  • Continually evaluate and drive improvements across finance operations
  • Assist with specific projects and initiatives unique to a fast-growing biotechnology start-up, such as system implementations and updates and business process improvements
  • Ad-Hoc Reporting and Analysis

Valo Health focuses on drug discovery and development in the biopharmaceutical sector, utilizing advanced technology to create new drugs and therapies. The company employs its proprietary Opal Computational platform, which integrates machine learning, tissue biology, and patient data to streamline the drug discovery process. This platform allows Valo Health to identify potential drug candidates more quickly and accurately than traditional methods. Unlike its competitors, Valo Health combines expertise from software engineers, data scientists, biologists, and medicinal chemists, fostering collaboration to tackle challenges in drug development. The company's goal is to improve health outcomes for patients worldwide by delivering effective solutions through partnerships with pharmaceutical companies and research institutions.

Company Stage

Series C

Total Funding

$548M

Headquarters

Boston, Massachusetts

Founded

2019

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

-24%
Simplify Jobs

Simplify's Take

What believers are saying

  • Valo Health's billion-dollar partnership with Novo Nordisk underscores its potential for significant financial growth and industry impact.
  • The company's leadership changes, including the appointment of Christian Schade as Executive Chairman and Graeme Bell as Interim CEO, signal a strategic realignment that could drive further innovation and growth.
  • Valo Health's collaboration with Charles River to launch Logica demonstrates its capability to transform drug discovery processes, potentially leading to groundbreaking treatments for neurodegenerative diseases and oncology.

What critics are saying

  • The highly competitive nature of the biopharmaceutical sector means Valo Health must continuously innovate to maintain its market position.
  • Leadership transitions, such as the recent appointment of an interim CEO, could lead to strategic uncertainties and operational disruptions.

What makes Valo Health unique

  • Valo Health's Opal Computational platform uniquely integrates machine learning, tissue biology, and patient data to accelerate drug discovery, setting it apart from traditional biopharmaceutical approaches.
  • The company's strategic partnerships with industry giants like Novo Nordisk and Charles River highlight its credibility and innovative edge in the biopharmaceutical sector.
  • Valo Health's ability to secure milestone payments and royalties from successful drug developments provides a diversified revenue stream, unlike many competitors who rely solely on direct sales.

Help us improve and share your feedback! Did you find this helpful?